NCT00236288View on ClinicalTrials.gov

A Feasibility Study of Smoking Cessation Program in Radiation Oncology

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

April 30, 2007

Conditions
Cancer and Tobacco Abuse
Interventions
DRUG

Bupropion and intensive behavioral therapy

To prescribe bupropion and behavioral therapy to patients and/or their families, who are currently receiving radiation.

Trial Locations (1)

46202

Indiana University, Department of Radiation Oncology, Indianapolis

All Listed Sponsors
collaborator

Walther Cancer Institute

OTHER

lead

Indiana University School of Medicine

OTHER

NCT00236288 - A Feasibility Study of Smoking Cessation Program in Radiation Oncology | Biotech Hunter | Biotech Hunter